Targeting specific protein regions offers a new treatment approach in Medulloblastoma (IMAGE)
Caption
Published today in the Journal of Nature Communications, Adam Durbin, MD, PhD, St. Jude Department of Oncology, demonstrated that by focusing on specific regions of EP300/CBP could enhance anti-tumor activity in Group 3 medulloblastoma.
Credit
St. Jude Children's Research Hospital
Usage Restrictions
None
License
Original content